<unk>  is used for the treatment of type 2 diabetes in adults. It can be used alone (if metformin therapy is ineffective or not tolerated) or in combination with other antidiabetic drugs, including insulins. According to a 2015 analysis,<unk>  is less effective than other GLP-1 agonists for lowering glycated hemoglobin (HbA1c, an indicator for long-term blood glucose control) and weight loss. It also seems to have fewer side effects than most other drugs of this class, except for reactions at the injection site which are more common under<unk>  than, for example, under liraglutide.
Albiglutide
Semaglutide
Teduglutide
Dulaglutide
Liraglutide
Linagliptin
Saxagliptin
Exenatide